The Broad Institute of Harvard and MIT will license ChemAxon's chemistry software platform, discovery toolkits and desktop applications for institute-wide use. Broad will support its legacy small molecule registration system and other functionality across its Chemical Biology Platform with ChemAxon’s technology.
In addition to ChemAxon’s discovery and desktop tools, the Broad Institute has already updated its core technology for archiving small molecules by deploying the JChem platform toolkit within its existing system.
'This adoption is a part of our strategy to provide our scientists in the Chemical Biology Platform with the most modern and capable tools to accelerate our research,' said Michael Foley, director of the Broad’s Chemical Biology Platform. 'The extensive capabilities of the ChemAxon software support our ongoing efforts to build and apply state of the art facilities to support our work.'
